Simplex Trading
DARE icon

Simplex Trading’s Dare Bioscience DARE Stock Holding History

Simplex Trading’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16
Closed -$1K – 6209
2017
Q1 		$1K Buy
16
+12
+300% +$1.73K ﹤0.01% 5593
2016
Q4 		$0 Sell
4
-10
-71% -$953 ﹤0.01% 5932
2016
Q3 		$1K Buy
+14
New +$3.14K ﹤0.01% 5278

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Simplex Trading's DARE Position: Q2 2017 in Review

Simplex Trading sold out of Dare Bioscience (DARE) in Q2 2017, closing a stake of 16 shares — an estimated $1K sold.

Simplex Trading first reported a position in DARE in Q3 2016 and held it in 3 quarters. The position peaked at $1K in Q1 2017. 19 funds tracked by Wall St. Rank hold DARE as of Q2 2017.

  • Simplex Trading reported no remaining Dare Bioscience position as of Q2 2017 after selling out during the quarter.
  • Simplex Trading sold 16 Dare Bioscience shares in Q2 2017, an estimated $1K.
  • Simplex Trading first reported a position in Dare Bioscience in Q3 2016 and held it in 3 quarters.
  • Simplex Trading's Dare Bioscience position peaked at $1K in Q1 2017.
  • 19 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2017.

Based on Simplex Trading's 13F filing for Q2 2017, filed 12 Jul 2017.